In the News Home Synthetic Biology The History of Synthetic Biology Living Medicines Designing Synthetic Biotic™ Medicines Pipeline + Programs Partner with Us For Patients Our People Leadership Board of Directors Founders and Advisors Join Us Investors + Media Company Overview News & Events News Releases Events In the News Presentations & Publications Stock Information Corporate Governance Financials Investor Resources Out On The (Cutting) Edge: How The Tools Of Extreme Survival Can Help Build A Biotech Company Source Life Sci VC May 18, 2022 Women Of The C-Suite: Dr Aoife Brennan Of Synlogic On The Five Things You Need To Succeed As A Senior Executive Source Authority Magazine May 1, 2022 Using Synthetic Biology to Treat Disease: A Chat with Synlogic's Jim Collins Source AIChE’s ChEnected April 28, 2022 Q&A With Aoife Brennan, president and CEO of Synlogic, Inc. Source PharmExec.com March 16, 2022 ‘We’re not going to get the all clear.’ More employers need to learn to live with COVID. Source The Boston Globe February 22, 2022 Synlogic CEO Aoife Brennan on Hybrid Work Source Kendall Square Association February 10, 2022 Current and Emerging Therapies for PKU (Including SYNB1618) Source Check Rare January 14, 2022 Positive Interim Data from Phase 2 Trial of Oral Drug for PKU Source Check Rare December 9, 2021 Behind the Paper: Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering Source Bioengineering Community by Nature Portfolio November 1, 2021 More than One Way to Fight Disease with Synbio Drugs Source Source: Genetic Engineering and Biotechnology News November 1, 2021 Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Email Alerts Contact IR RSS Feeds Print Page Email Page
Out On The (Cutting) Edge: How The Tools Of Extreme Survival Can Help Build A Biotech Company Source Life Sci VC May 18, 2022 Women Of The C-Suite: Dr Aoife Brennan Of Synlogic On The Five Things You Need To Succeed As A Senior Executive Source Authority Magazine May 1, 2022 Using Synthetic Biology to Treat Disease: A Chat with Synlogic's Jim Collins Source AIChE’s ChEnected April 28, 2022 Q&A With Aoife Brennan, president and CEO of Synlogic, Inc. Source PharmExec.com March 16, 2022 ‘We’re not going to get the all clear.’ More employers need to learn to live with COVID. Source The Boston Globe February 22, 2022 Synlogic CEO Aoife Brennan on Hybrid Work Source Kendall Square Association February 10, 2022 Current and Emerging Therapies for PKU (Including SYNB1618) Source Check Rare January 14, 2022 Positive Interim Data from Phase 2 Trial of Oral Drug for PKU Source Check Rare December 9, 2021 Behind the Paper: Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering Source Bioengineering Community by Nature Portfolio November 1, 2021 More than One Way to Fight Disease with Synbio Drugs Source Source: Genetic Engineering and Biotechnology News November 1, 2021 Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
Out On The (Cutting) Edge: How The Tools Of Extreme Survival Can Help Build A Biotech Company Source Life Sci VC May 18, 2022
Women Of The C-Suite: Dr Aoife Brennan Of Synlogic On The Five Things You Need To Succeed As A Senior Executive Source Authority Magazine May 1, 2022
Using Synthetic Biology to Treat Disease: A Chat with Synlogic's Jim Collins Source AIChE’s ChEnected April 28, 2022
‘We’re not going to get the all clear.’ More employers need to learn to live with COVID. Source The Boston Globe February 22, 2022
Behind the Paper: Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering Source Bioengineering Community by Nature Portfolio November 1, 2021
More than One Way to Fight Disease with Synbio Drugs Source Source: Genetic Engineering and Biotechnology News November 1, 2021